ACVR2B antagonism as a countermeasure to multi‐organ perturbations in metastatic colorectal cancer cachexia

BACKGROUND: Advanced colorectal cancer (CRC) is often accompanied by the development of liver metastases, as well as cachexia, a multi‐organ co‐morbidity primarily affecting skeletal (SKM) and cardiac muscles. Activin receptor type 2B (ACVR2B) signalling is known to cause SKM wasting, and its inhibi...

Descripción completa

Detalles Bibliográficos
Autores principales: Huot, Joshua R., Pin, Fabrizio, Narasimhan, Ashok, Novinger, Leah J., Keith, Austin S., Zimmers, Teresa A., Willis, Monte S., Bonetto, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7749603/
https://www.ncbi.nlm.nih.gov/pubmed/33200567
http://dx.doi.org/10.1002/jcsm.12642

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7749603/
https://www.ncbi.nlm.nih.gov/pubmed/33200567
http://dx.doi.org/10.1002/jcsm.12642

Ejemplares similares